PLOD2 and renal cell carcinoma: To further investigate that dm6ACRISPR targeting PLOD2 whether can modulate RCC cells proliferation, we performed 5-ethynyl-20-deoxyuridine (EdU) and cell counting kit-8 (CCK-8) assays to evaluate the proliferative activity of RCC cells after dm6ACRISPR targeting PLOD2 in 786-O and OSRC RCC cells.